An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc).
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2014
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 11 Apr 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 13 Feb 2012 Planned end date changed from 1 Feb 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.